MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ctr.70187

Медицинская библиотека · Clinical transplantation · 2025

Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients.

Coppola John-Anthony, Shirley Debbie-Ann, Martin Emily, Probst Varvara, Gupta Dipankar

СтатьяКлинический случайПеревод в очереди

Аннотация

INTRODUCTION

Cytomegalovirus (CMV) is a prevalent DNA virus that is a well-recognized cause of significant complications in post-transplant recipients. Emergence of CMV resistance to standard antiviral agents poses a substantial challenge for appropriate management post-transplantation. Currently, there are no pediatric heart transplant data on the use of novel agents such as letermovir for the management of resistant CMV infection.

METHODS

We present our experience using letermovir in the management of three pediatric heart transplant recipients with CMV infection who developed resistance to standard therapy. Informed consent was not required.

RESULTS

Letermovir was successfully used for secondary prophylaxis in three patients, all with ganciclovir resistant CMV infection due to UL97 mutations, with no evidence of CMV breakthrough infection and no significant side effects observed.

CONCLUSION

In our experience, letermovir was well tolerated and effective in the management of resistant CMV in pediatric heart transplant recipients.

Для цитирования: Coppola John-Anthony, Shirley Debbie-Ann, Martin Emily, Probst Varvara, Gupta Dipankar. Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients.. Clinical transplantation. 2025. DOI: 10.1111/ctr.70187.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.